Department of Microbiology & Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada.
Int J Mol Sci. 2024 Sep 2;25(17):9529. doi: 10.3390/ijms25179529.
We recently reported in a rat model of kidney transplantation that the addition of sodium thiosulfate (STS) to organ preservation solution improved renal graft quality and prolonged recipient survival. The present study investigates whether STS pre-treatment would produce a similar effect. In vitro, rat kidney epithelial cells were treated with 150 μM STS before and/or during exposure to hypoxia followed by reoxygenation. In vivo, donor rats were treated with PBS or 2.4 mg/kg STS 30 min before donor kidneys were procured and stored in UW or UW+150 μM STS solution at 4 °C for 24 h. Renal grafts were then transplanted into bilaterally nephrectomised recipient rats which were then sacrificed on post-operative day 3. STS pre-treatment significantly reduced cell death compared to untreated and other treated cells in vitro ( < 0.05), which corresponded with our in vivo result ( < 0.05). However, no significant differences were observed in other parameters of tissue injury. Our results suggest that STS pre-treatment may improve renal graft function after transplantation.
我们最近在大鼠肾移植模型中报道,在器官保存液中添加硫代硫酸钠(STS)可改善移植物质量并延长受体存活时间。本研究旨在探讨 STS 预处理是否会产生类似的效果。在体外,用 150μM STS 处理大鼠肾上皮细胞,然后在缺氧后再进行复氧。在体内,供体大鼠在获取供体肾脏前 30 分钟用 PBS 或 2.4mg/kg STS 处理,并将其储存在 UW 或 UW+150μM STS 溶液中 4°C 24 小时。然后将肾移植物移植到双侧肾切除的受体大鼠中,术后第 3 天处死。与未处理和其他处理的细胞相比,STS 预处理可显著减少细胞死亡(<0.05),这与我们的体内结果一致(<0.05)。然而,在组织损伤的其他参数方面没有观察到显著差异。我们的结果表明,STS 预处理可能改善移植后肾移植物的功能。